Skip to content
OpenCapital
Get started

GE HealthCare Technologies GEHC Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

HTF
Heartflow, Inc. Common StockHTFL
-$1.43M-29.6%
Teledyne Technologies logo
Teledyne TechnologiesTDY
-$35.7M-18.2%

Other financials

Income statement

See full
Revenue$5.3B+5.8%
Gross profit$2.2B+9.8%
Operating income$739.0M+13.0%
Net income$561.0M+15.4%
EPS (diluted)$1.24+17.0%

Balance sheet

See full
Total debt$10.5B-1.6%
Total equity$11.0B+13.0%
Total assets$37.2B+4.9%

Cash flow

See full
Operating cash flow$168.0M+78.7%
CapEx$100.0M+16.3%
Free cash flow$68.0M+750%

Valuation

See full
Market cap$29.16B-18.1%
P/E14.7×-1.2×
P/S1.4×-0.4×

Profitability

See full
Gross margin39.5%-2.0pp
Operating margin12.9%-1.0pp
Net margin9.3%-1.9pp
FCF margin7.4%-0.4pp

Returns & leverage

See full
Return on equity19.2%-6.4pp
Debt / equity1×-0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: GE HealthCare Technologies’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation?
GE HealthCare Technologies (GEHC) reported cash provided by (used in) investing activity, including discontinued operation of -$115M in Q2 2026.
How has GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation increased by 48.4% year-over-year, from -$223M to -$115M.
What is the long-term trend for GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation?
Over 4 years (2021 to 2025), GE HealthCare Technologies's cash provided by (used in) investing activity, including discontinued operation has grown at a -12.2% compound annual growth rate (CAGR), from -$1.76B to -$1.05B.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.